New York · 2025 Regular Session · Bill
S 621: Relates to the use of topical pharmaceutical agents
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 621 is a bill introduced in the New York Senate on January 8, 2025. According to its official title, it concerns: Relates to the use of topical pharmaceutical agents. Primary sponsor: John Liu (Democratic). It lists 4 additional sponsors. Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Sponsors
Sponsors by party (alphabetical): Democratic 3 · Republican 1 · Republican/Conservative 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| John Liu | Primary sponsor | Democratic | Senate | 16 |
| Joe Addabbo | Co-sponsor | Democratic | Senate | 15 |
| Peter Oberacker | Co-sponsor | Republican/Conservative | Senate | 51 |
| Rob Rolison | Co-sponsor | Republican | Senate | 39 |
| Jessica Scarcella-Spanton | Co-sponsor | Democratic | Senate | 23 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HIGHER EDUCATION
- REFERRED TO HIGHER EDUCATION